Cargando…
Is Adjuvant Chemotherapy Beneficial to All Patients With pT3N0M0 Stage Gastric Cancer?
BACKGROUND: The efficacy and benefits of adjuvant chemotherapy (AC) for patients with gastric cancer pT3N0M0 remain controversial. METHODS: We prospectively collected and retrospectively analyzed 235 patients with pT3N0M0 gastric cancer who underwent radical resection between February 2010 and Janua...
Autores principales: | Huang, Jiao-Bao, Lu, Jun, Wu, Dong, Xu, Bin-bin, Xue, Zhen, Lin, Guo-Sheng, Zheng, Hua-Long, Shen, Li-li, Lin, Jia, Xie, Jian-Wei, Wang, Jia-Bin, Lin, Jian-Xian, Chen, Qi-Yue, Cao, Long-Long, Zheng, Chao-Hui, Huang, Chang-Ming, Li, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428976/ https://www.ncbi.nlm.nih.gov/pubmed/34513692 http://dx.doi.org/10.3389/fonc.2021.712432 |
Ejemplares similares
-
Indications for adjuvant chemotherapy in patients with AJCC stage IIa T3N0M0 and T1N2M0 gastric cancer—an east and west multicenter study
por: Huang, Ze-Ning, et al.
Publicado: (2019) -
Does Tumor Size Improve the Accuracy of Prognostic Predictions in Node-Negative Gastric Cancer (pT1-4aN0M0 Stage)?
por: Xu, Mu, et al.
Publicado: (2014) -
Evaluation of dynamic recurrence risk for locally advanced gastric cancer in the clinical setting of adjuvant chemotherapy: a real-world study with IPTW-based conditional recurrence analysis
por: Wu, Dong, et al.
Publicado: (2023) -
An immune checkpoint score system for prognostic evaluation and adjuvant chemotherapy selection in gastric cancer
por: Wang, Jia-Bin, et al.
Publicado: (2020) -
Association of Adjuvant Chemotherapy With Overall Survival Among Patients With Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
por: Lin, Jian-Xian, et al.
Publicado: (2022)